Showing results (461-470 of 504) with videos related to

Sort By:
Pageof 51
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
The Journal of Urology|November 19, 2011
Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white menThomas Rhodes, Debra J Jacobson, Michaela E McGree, et al.
Genetics|July 14, 2011
Massive changes in genome architecture accompany the transition to self-fertility in the filamentous fungus Neurospora tetraspermaChristopher E Ellison, Jason E Stajich, David J Jacobson, et al.
The Journal of Urology|November 19, 2011
Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white menThomas Rhodes, Debra J Jacobson, Michaela E McGree, et al.
Cancer|August 15, 1996
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsL H Wexler, T F DeLaney, M Tsokos, et al.
Journal of the National Cancer Institute|May 19, 1993
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapyD C Case, R M Bukowski, R W Carey, et al.
Mycologia|December 15, 2010
Neurospora in temperate forests of western North AmericaDavid J Jacobson, Amy J Powell, Jeremy R Dettman, et al.
Urology|February 8, 2006
Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of menRebecca J Mullan, Eric J Bergstralh, Sara A Farmer, et al.
Blood|October 15, 1995
A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapyJ A O'Shaughnessy, D J Venzon, M Gossard, et al.
Blood|March 15, 1996
Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancerJ A O'Shaughnessy, A Tolcher, D Riseberg, et al.
Pageof 51